Inflammatory Bowel Disease (Crohn Disease vs. Ulcerative Colitis) — Clinical Compendium

Crohn Disease Hallmarks

Transmural inflammation from mouth to anus (terminal ileum #1, rectal sparing), skip lesions, noncaseating granulomas, cobblestone mucosa, creeping fat, string sign, ASCA+.

Ulcerative Colitis Hallmarks

Mucosal & submucosal inflammation, always involves rectum and extends continuously proximally, friable bloody diarrhea, crypt abscesses, pseudopolyps, lead-pipe colon, p-ANCA+.

Extraintestinal Activity

Parallels bowel activity: Erythema nodosum, peripheral arthritis, episcleritis. Independent of bowel activity: PSC, Ankylosing spondylitis, Uveitis, Pyoderma gangrenosum.

5-ASA & Sulfasalazine

First-line induction/maintenance for mild-to-moderate Ulcerative Colitis: Mesalamine (5-ASA). Sulfasalazine causes folate deficiency and reversible oligospermia.

Biologic Pre-Screening

Before starting Anti-TNF agents (Infliximab, Adalimumab), ALWAYS screen for Latent Tuberculosis (IGRA/PPD) and Hepatitis B (HBsAg/anti-HBc). Check TPMT before Azathioprine/6-MP.

Toxic Megacolon

Transverse colon > 6 cm + systemic toxicity; NPO, NG decompression, IV corticosteroids, broad-spectrum antibiotics; avoid opioids/loperamide/colonoscopy/barium!

CRC Surveillance Rule

Initiate colonoscopy with chromoendoscopy/targeted biopsies 8 years after symptom onset for pancolitis/left-sided colitis (q1–3 yrs), or IMMEDIATELY at diagnosis (and annually) if comorbid PSC!

Cannon-Böhm Transition

Proximal to distal 1/3 transverse colon: T10–T11 (SMG) + Vagus (CN X). Distal colon to rectum: T12–L2 (IMG) + Pelvic Splanchnics (S2–S4).

Comprehensive Comparison: Crohn Disease vs. Ulcerative Colitis

Inflammatory Bowel Disease (IBD) comprises two chronic, relapsing immune-mediated gastrointestinal disorders—Crohn Disease and Ulcerative Colitis (UC)—that differ fundamentally in their anatomical distribution, depth of mural inflammation, endoscopic morphology, histopathology, and surgical curability. Distinguishing skip-lesion transmural Crohn disease from continuous mucosal rectocolonic UC is essential before initiating biologic therapy or recommending colectomy.

Stool consistency across diarrheal and constipation syndromes is classified via the Bristol Stool Form Scale (Bristol Stool Scale / Bristol Type 1 pellets to Type 7). Radiographically, chronic ulcerative colitis produces a featureless Lead Pipe Colon (featureless colon) on barium enema, whereas stenosing colorectal adenocarcinoma produces an Apple-Core Lesion (napkin ring lesion).

Characteristic	Crohn Disease	Ulcerative Colitis
Gastrointestinal Location	Any segment from mouth to anus (terminal ileum most common); rectal sparing common	Colon only; always starts at the rectum and progresses proximally continuously
Depth of Inflammation	Transmural (causes fistulas, strictures, deep fissures, bowel obstruction)	Mucosal and submucosal only (causes superficial ulcerations and pseudopolyps)
Endoscopic Pattern	Skip lesions with intervening normal mucosa, aphthous ulcers, cobblestone appearance	Continuous circumferential erythema, loss of vascular markings, friable mucosa
Histopathology	Noncaseating granulomas (pathognomonic), transmural lymphoid aggregates	Crypt abscesses containing neutrophils, crypt architectural distortion
Smoking Effect	Smoking increases risk, recurrence, and surgical requirement	Smoking appears protective; smoking cessation frequently precipitates disease flare

Anatomical & Histopathologic Divergence: Transmural Crohn vs. Mucosal Ulcerative Colitis

Crohn Disease is a disordered Th1/Th17 cell-mediated immune response capable of affecting any segment of the gastrointestinal tract from mouth (aphthous ulcers) to anus, most commonly involving the terminal ileum and proximal colon (ileocolitis) while characteristically sparing the rectum. Because inflammation is transmural (extending through the mucosa, submucosa, muscularis propria, and subserosal fat, accompanied by mesenteric 'creeping fat'), patients develop deep linearknife-like fissures alternating with edematous mucosa (endoscopic 'cobblestone' appearance and skip lesions), fibrotic strictures ('string sign' on barium imaging), enteroenteric/perianal fistulas, and pathognomonic non-caseating granulomas on biopsy. Conversely, Ulcerative Colitis (UC) is a Th2-skewed inflammatory process strictly limited to the mucosa and submucosa of the colon and rectum: it always begins in the rectum (proctitis) and extends proximally in a continuous, uninterrupted circumferential front up to the cecum (never involving the small intestine except mild 'backwash ileitis'), producing friable mucosa with pseudopolyps, loss of haustral markings ('lead-pipe colon'), and crypt abscesses (neutrophil accumulation within colonic crypts) and crypt architectural branching without granulomas.

Cigarette Smoking Paradox, Vitamin/Bile Salt Malabsorption & Serologic Markers (ASCA vs. p-ANCA)

Two epidemiological and pathophysiological contrasts distinguish Crohn disease from UC on board exams: (1) The Cigarette Smoking Paradox: cigarette smoking doubles the risk and worsens flares of Crohn disease, whereas smoking is protective against Ulcerative Colitis (UC classically flares or presents de novo shortly after a patient quits smoking!). (2) Terminal Ileal Malabsorption Sequelae in Crohn Disease: because the terminal ileum is the exclusive site for both Vitamin B12–Intrinsic Factor receptor absorption and enterohepatic bile salt reabsorption, terminal ileal Crohn disease or resection (>100 cm) causes megaloblastic anemia with subacute combined degeneration, fat-soluble vitamin deficiencies (A, D, E, K), cholesterol gallstones (from bile salt pool depletion), and calcium oxalate kidney stones (unabsorbed intraluminal fatty acids chelate dietary calcium, leaving free oxalate to be hyperabsorbed in the colon). Serologically, Crohn disease is associated with anti-Saccharomyces cerevisiae antibodies (ASCA), whereas Ulcerative Colitis (and Primary Sclerosing Cholangitis) is associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA).

Extraintestinal Manifestations of IBD

Extraintestinal manifestations occur in 25-40% of patients and may parallel bowel activity or run an independent course:

Parallels Bowel Activity: Erythema nodosum, peripheral arthritis, episcleritis, aphthous stomatitis (treat by inducing bowel remission).
Independent of Bowel Activity: Pyoderma gangrenosum (deep, necrotic ulcer with violaceous borders; do not debride), Ankylosing spondylitis (HLA-B27), Primary Sclerosing Cholangitis (strongly associated with UC; causes bead-like strictures on MRCP).

Organ System	Manifestation	Correlation with Bowel Flare Activity	Pathophysiology & Management
Cutaneous	Erythema Nodosum vs. Pyoderma Gangrenosum	Erythema Nodosum PARALLELS bowel activity; Pyoderma Gangrenosum is variable/independent	EN: tender erythematous nodules on anterior shins (septal panniculitis); resolves with treating IBD flare. PG: painful violaceous ulcer with undermined borders and pathergy (neutrophilic dermatosis); treat with systemic steroids/infliximab
Hepatobiliary	Primary Sclerosing Cholangitis (PSC)	INDEPENDENT of bowel activity (persists even after total proctocolectomy!)	Strongly associated with Ulcerative Colitis (80% of PSC patients have UC); p-ANCA positive, 'beading' of intra/extrahepatic bile ducts on MRCP, onion-skin periductal fibrosis; high risk of cholangiocarcinoma and colorectal cancer (annual colonoscopy)
Musculoskeletal	Peripheral Pause-Articular Arthritis vs. Axial Ankylosing Spondylitis / Sacroiliitis	Peripheral migratory arthritis PARALLELS bowel activity; Axial spondylitis/sacroiliitis is INDEPENDENT	HLA-B27 positive in axial spondylitis; NEVER use NSAIDs for arthritis in IBD patients because NSAIDs precipitate severe mucosal ulceration and IBD flares (use sulfasalazine or anti-TNF biologics instead)
Ocular & Renal	Episcleritis vs. Anterior Uveitis (Iritis); Calcium Oxalate Nephrolithiasis	Episcleritis PARALLELS bowel activity; Uveitis is INDEPENDENT	Episcleritis: painless/mildly tender sectoral scleral injection. Uveitis: painful red eye, photophobia, miosis (slit-lamp leukocytes in anterior chamber; urgent topical steroids). Crohn ileitis/resection causes fat malabsorption -> Ca2+ binds fatty acids -> unbound oxalate reabsorbed in colon -> Ca-oxalate stones

Histopathology and clinical presentation of erythema nodosum septal panniculitis — **Erythema Nodosum (Delayed Hypersensitivity Septal Panniculitis in IBD):** Tender erythematous nodules over the anterior shins caused by septal panniculitis without vasculitis—the most common cutaneous extraintestinal manifestation of IBD, which parallels intestinal flare activity. View Full Resolution

Manifestations That Parallel Bowel Activity vs. Those That Run an Independent Course

When an IBD patient presents with an extraintestinal complaint, board questions test whether treating the underlying intestinal inflammation (or performing a curative colectomy in UC) will resolve the extraintestinal manifestation: Manifestations that PARALLEL intestinal flare activity include Peripheral Pauciarticular Arthritis (asymmetric, migratory, non-deforming large-joint arthritis), Erythema Nodosum (tender red nodules on the anterior shins from septal panniculitis), Episcleritis (mildly tender sectoral scleral hyperemia that blanches with topical phenylephrine), and Aphthous Stomatitis. Conversely, Manifestations that run an INDEPENDENT course (and persist even after total proctocolectomy in UC!) include Primary Sclerosing Cholangitis (PSC), Ankylosing Spondylitis and Sacroiliitis (HLA-B27 positive), Anterior Uveitis / Iritis (painful red eye with photophobia, miosis, and perilimbal ciliary flush requiring urgent slit-lamp exam and topical steroids), and Pyoderma Gangrenosum (often independent in severe disease).

Primary Sclerosing Cholangitis (PSC) Surveillance & Colorectal Cancer Screening Rules in IBD

Primary Sclerosing Cholangitis (PSC)—presenting with pruritus, fatigue, cholestatic liver panel (markedly elevated alkaline phosphatase and GGT), positive p-ANCA, multifocal intrahepatic and extrahepatic biliary strictures and dilations ('beading on a string' on MRCP), and concentric 'onion-skin' periductal fibrosis on biopsy—occurs primarily in young men with Ulcerative Colitis. PSC dramatically elevates the lifetime risk of both cholangiocarcinoma (screened every 6–12 months with MRCP/ultrasound and CA 19-9) and colorectal adenocarcinoma. Standard IBD colorectal cancer surveillance begins 8 years after symptom onset for extensive colitis (left-sided or pancolitis; proctitis alone does not increase risk) with colonoscopy every 1 to 3 years; however, if a patient is diagnosed with concomitant PSC and IBD, surveillance colonoscopy must begin IMMEDIATELY at the time of PSC diagnosis and be repeated EVERY 1 YEAR.

Pathophysiology, Endoscopic/Histologic Hallmarks & Radiographic Signatures

Inflammatory Bowel Disease (IBD) comprises two distinct chronic idiopathic immune-mediated gastrointestinal disorders—Crohn Disease (CD) and Ulcerative Colitis (UC)—resulting from dysregulated mucosal immune responses to commensal intestinal microbiota in genetically susceptible hosts. Both exhibit a bimodal age distribution (primary peak at ages 15–30, secondary peak at ages 50–70) and Ashkenazi Jewish ethnic predisposition. Immunologically, Crohn disease is linked to germline frameshift mutations in the NOD2 / CARD15 gene (an intracellular pattern-recognition receptor in Paneth cells that senses bacterial muramyl dipeptide) and ATG16L1 (autophagy), driving a Th1 and Th17 cell-mediated immune response (secreting IFN-γ, TNF-α, IL-12, and IL-23) that produces deep, full-thickness transmural granulomatous inflammation. Conversely, Ulcerative Colitis is driven by an atypical Th2 and NK T-cell response (secreting IL-5 and IL-13) that restricts cytotoxic damage strictly to the epithelial mucosa and submucosa.

Diagnostic Domain	Crohn Disease (CD)	Ulcerative Colitis (UC)
Anatomical Distribution	Any GI segment from mouth to anus; Terminal ileum & cecum most common (ileocolitis, 50%); Rectum is frequently SPARED; prominent perianal disease	Restricted strictly to the colon & rectum (except rare 'backwash ileitis'); ALWAYS involves the rectum and extends proximally in a continuous, uninterrupted sheet
Gross & Endoscopic Pattern	Discontinuous 'skip lesions'; early pinpoint aphthous ulcers coalescing into deep longitudinal/serpiginous linear ulcers framing normal edematous mucosa ('cobblestone' appearance); creeping mesenteric fat	Continuous, circumferential erythematous, friable mucosa with loss of vascular markings and inflammatory pseudopolyps (regenerating mucosal islands amidst ulceration)
Microscopic Histopathology	Transmural inflammation across all bowel wall layers (mucosa through serosa), deep knife-like fissuring ulcers, and pathognomonic Noncaseating Granulomas (found in 35–50% of biopsies)	Inflammation confined strictly to Mucosa and Submucosa; Neutrophilic Crypt Abscesses, cryptitis, basal plasmacytosis, and crypt branching/atrophy (NO granulomas!)
Radiographic Hallmark	'String sign' on barium small-bowel follow-through / CT enterography due to severe fibrotic luminal narrowing and wall thickening in the terminal ileum	'Lead-pipe' colon on abdominal X-ray / barium study due to complete loss of colonic haustral markings and foreshortening from chronic mucosal fibrosis
Serology & Tobacco Effect	ASCA positive (Anti-Saccharomyces cerevisiae antibodies); Cigarette smoking WORSENS disease, increases flares, and doubles surgical recurrence	p-ANCA positive (perinuclear anti-neutrophil cytoplasmic antibodies); Cigarette smoking is PROTECTIVE (smoking cessation often triggers first UC flare)
Primary Clinical Presentation	Crampy right lower quadrant (RLQ) abdominal pain (mimics appendicitis), non-bloody watery diarrhea (bloody if colonic), weight loss, palpable RLQ mass, oral aphthous ulcers	Frequent small-volume bloody, mucoid diarrhea, tenesmus, rectal urgency, and crampy left lower quadrant (LLQ) abdominal pain
Structural & Metabolic Complications	Fistulas (enterovesical, enterocutaneous, rectovaginal, perianal), fibrotic strictures / small bowel obstruction, intra-abdominal abscesses, Vitamin B₁₂ / bile acid malabsorption, Ca-oxalate kidney stones, gallstones	Toxic Megacolon, fulminant hemorrhage, free colonic perforation, Primary Sclerosing Cholangitis (PSC), and high risk of Colorectal Adenocarcinoma

Crohn Disease Histopathology showing Noncaseating Granuloma and Transmural Inflammation — **Crohn Disease Noncaseating Granuloma & Transmural Lymphoid Aggregates:** Full-thickness transmural chronic inflammatory infiltrate with well-circumscribed noncaseating epithelioid cell granulomas and multinucleated Langhans giant cells in the submucosa and muscularis propria. View Full Resolution

Fecal Calprotectin / Lactoferrin vs. IBS Differentiation

Young adults presenting with chronic abdominal pain and diarrhea often require differentiation between functional Irritable Bowel Syndrome (IBS) and early Inflammatory Bowel Disease. Unlike IBS (which has normal ESR/CRP, normal fecal markers, and absence of nocturnal symptoms, weight loss, or hematochezia), active IBD releases cytosolic neutrophil proteins into the intestinal lumen: Fecal Calprotectin and Fecal Lactoferrin are highly sensitive (> 90%) and specific non-invasive biomarkers of neutrophilic intestinal inflammation that distinguish organic IBD from functional IBS and track mucosal healing during biologic therapy.

Malabsorptive Sequelae of Terminal Ileal Crohn Disease

Because the terminal ileum is the exclusive anatomic site for active reabsorption of conjugated bile salts and Intrinsic Factor–Vitamin B₁₂ complexes, terminal ileal Crohn inflammation or surgical resection (> 100 cm) produces three classic board-tested metabolic complications: (1) Megaloblastic macrocytic anemia and subacute combined degeneration from Vitamin B₁₂ deficiency (requires lifelong monthly intramuscular or high-dose sublingual cyanocobalamin); (2) Cholesterol gallstones (loss of enterohepatic bile acid recycling depletes the hepatic bile salt pool, causing biliary cholesterol supersaturation); and (3) Calcium oxalate nephrolithiasis (enteric hyperoxaluria)—normally, intraluminal calcium binds dietary oxalate to form insoluble calcium oxalate excreted in stool; in fat malabsorption, unabsorbed fatty acids avidly chelate calcium ('saponification'), leaving free oxalate to be absorbed in the colon and excreted by the kidneys.

Extraintestinal Manifestations: Activity-Dependent vs. Activity-Independent

Board questions frequently ask whether treating the underlying bowel flare will resolve an extraintestinal symptom. Manifestations that PARALLEL intestinal disease activity (and resolve when the bowel flare is controlled medically or surgically) include Peripheral Migratory Oligoarthritis/Polyarthritis (non-erosive, asymmetric large-joint arthritis), Erythema Nodosum (tender erythematous subcutaneous nodules on the anterior shins from septal panniculitis), Episcleritis (painless scleral injection without vision loss), and Aphthous Stomatitis. Conversely, manifestations that run an INDEPENDENT course from bowel activity (and DO NOT resolve even after total proctocolectomy in UC!) include Primary Sclerosing Cholangitis (PSC), Ankylosing Spondylitis / Sacroiliitis (HLA-B27), Anterior Uveitis (painful red eye with photophobia and blurred vision—slit-lamp emergency!), and Pyoderma Gangrenosum (typically independent, though occasionally responsive to bowel biologics).

Stepwise Medical Management & Pharmacology of Ulcerative Colitis and Crohn Disease

Modern IBD pharmacotherapy separates induction of remission (rapidly halting an acute inflammatory flare) from maintenance of remission (long-term steroid-free mucosal healing). A fundamental clinical principle is that systemic corticosteroids (oral Prednisone, oral Budesonide, IV Methylprednisolone/Hydrocortisone) are strictly induction agents and must NEVER be used for chronic maintenance therapy due to osteonecrosis, osteoporosis, adrenal suppression, cataracts, and opportunistic infections. Furthermore, while 5-aminosalicylates (5-ASA / Mesalamine) are the cornerstone forboth induction and maintenance of mild-to-moderate Ulcerative Colitis, oral 5-ASA agents have negligible mucosal efficacy in transmural Crohn Disease, where early introduction of biologics (Anti-TNF, Anti-Integrin, Anti-IL-12/23) with or without immunomodulators prevents irreversible stricturing and fistulizing damage.

Drug Class & Agents	Molecular Mechanism of Action	Primary Clinical Indications (UC vs. CD)	High-Yield Adverse Effects & Mandatory Monitoring
5-Aminosalicylates (5-ASA): Mesalamine, Sulfasalazine, Balsalazide, Olsalazine	Topical colonic mucosal anti-inflammatory: inhibits COX/lipoxygenase (leukotrienes/PGs), scavenges ROS, and inhibits NF-κB	First-line induction & maintenance for mild-to-moderate Ulcerative Colitis: Rectal suppositories (proctitis), Rectal enemas (left-sided colitis), Oral + Rectal (pancolitis)	Sulfasalazine (5-ASA linked to sulfapyridine via azo bond cleaved by colonic bacteria): sulfa allergy, G6PD hemolysis, folate malabsorption (supplement folic acid!), reversible oligospermia; Mesalamine: interstitial nephritis
Corticosteroids: Budesonide, Prednisone, IV Methylprednisolone	Binds cytosolic glucocorticoid receptors → inhibits phospholipase A₂, NF-κB, and pro-inflammatory cytokines. Budesonide undergoes > 90% first-pass hepatic metabolism	Acute flare INDUCTION ONLY (NEVER for maintenance!): Oral enteric-coated Budesonide for mild-moderate ileocecal Crohn or mild-moderate UC; IV steroids for severe flares	Hyperglycemia, osteoporosis (give Ca²⁺/Vit D + DEXA), avascular necrosis of femoral head, Cushingoid features, adrenal suppression
Thiopurine Immunomodulators: Azathioprine (AZA), 6-Mercaptopurine (6-MP)	Purine antimetabolite prodrugs converted to 6-thioguanine nucleotides that inhibit de novo purine synthesis in T/B lymphocytes (takes 3–6 months for full effect)	Steroid-sparing maintenance in Crohn and UC; often combined with Infliximab to prevent anti-drug neutralizing antibodies	Check TPMT (thiopurine methyltransferase) enzyme/genotype FIRST! Myelosuppression/leukopenia, acute pancreatitis, hepatotoxicity; Allopurinol inhibits xanthine oxidase → fatal 6-MP toxicity!
Anti-TNF-α Biologics: Infliximab (IV), Adalimumab (SC), Certolizumab, Golimumab	Monoclonal antibodies that bind soluble and transmembrane TNF-α, inducing apoptosis of activated lamina propria T-cells and macrophages	First-line induction & maintenance for moderate-to-severe Crohn Disease, Fistulizing/Perianal Crohn, and moderate-to-severe/steroid-refractory UC	Reactivation of Latent TB & Hepatitis B (mandatory IGRA/PPD & HBV panel before starting!); demyelinating disease, drug-induced lupus, worsening heart failure, hepatosplenic T-cell lymphoma
Anti-Integrin Biologics: Vedolizumab, Natalizumab	Vedolizumab binds α₄β₇ integrin (gut-selective MAdCAM-1 blockade). Natalizumab binds α₄ integrin (blocks both gut α₄β₇ and CNS α₄β₁ VCAM-1)	Moderate-to-severe UC and Crohn disease (Vedolizumab is favored in elderly or infection-prone patients due to gut-specific immunosuppression)	Natalizumab causes Progressive Multifocal Leukoencephalopathy (PML) from JC polyomavirus reactivation (Vedolizumab does NOT cross blood-brain barrier and has virtually zero PML risk!)
Anti-IL-12/23 & JAK Inhibitors: Ustekinumab, Risankizumab, Tofacitinib, Upadacitinib	Ustekinumab binds p40 subunit of IL-12 & IL-23 (Risankizumab binds p19 of IL-23). Tofacitinib/Upadacitinib are oral small-molecule JAK-STAT inhibitors	Moderate-to-severe Crohn disease and Ulcerative Colitis (including anti-TNF failures)	JAK inhibitors: Herpes zoster (shingles) reactivation, venous thromboembolism (DVT/PE), hyperlipidemia, major adverse cardiovascular events

Ulcerative Colitis Lead-Pipe Colon and Crypt Abscess Histopathology — **Ulcerative Colitis: Lead-Pipe Colon & Neutrophilic Crypt Abscesses:** Left: Barium enema / abdominal radiograph demonstrating complete loss of colonic haustrations ('lead-pipe colon'). Right: Mucosal biopsy showing dense lamina propria inflammation and neutrophils filling dilated mucosal crypts (crypt abscesses). View Full Resolution

Anatomical Tailoring of 5-ASA in Mild-to-Moderate Ulcerative Colitis

In mild-to-moderate Ulcerative Colitis, matching the 5-ASA formulation to the anatomical extent of colonic inflammation maximizes mucosal drug concentration: (1) Ulcerative Proctitis (confined to the rectum, < 18 cm): first-line therapy is topical Mesalamine rectal suppositories (superior to oral 5-ASA!); (2) Left-Sided Ulcerative Colitis / Proctosigmoiditis (extending up to the splenic flexure): combine topical Mesalamine rectal enemas/foam with oral Mesalamine; and (3) Extensive Colitis or Pancolitis (extending proximal to the splenic flexure): administer high-dose oral Mesalamine plus topical rectal Mesalamine.

Why TPMT Testing and Xanthine Oxidase Caution Are Mandatory Before Azathioprine / 6-MP

Azathioprine is non-enzymatically cleaved in vivo to 6-Mercaptopurine (6-MP), which is inactivated via two competing pathways: methylation by Thiopurine Methyltransferase (TPMT) and oxidation by Xanthine Oxidase (XO). Patients with autosomal recessive TPMT deficiency (or patients taking the xanthine oxidase inhibitors Allopurinol or Febuxostat for gout) shunt all 6-MP into active cytotoxic 6-thioguanine nucleotides, resulting in life-threatening pancytopenia and bone marrow aplasia. Always assay TPMT phenotype/genotype (and NUDT15) prior to initiating thiopurines!

Acute Severe Ulcerative Colitis, Toxic Megacolon & Perianal/Fistulizing Crohn Complications

Acute Severe Ulcerative Colitis (defined by Truelove and Witts criteria: ≥ 6 bloody bowel movements per day PLUS at least one marker of systemic toxicity—fever > 37.8°C, heart rate > 90 bpm, hemoglobin < 10.5 g/dL, or ESR > 30 mm/hr / elevated CRP) is a medical emergency requiring immediate hospitalization. Progression of inflammation into the muscularis propria triggers inducible nitric oxide synthase (iNOS) release of nitric oxide and VIP, paralyzing colonic smooth muscle tone and causing Toxic Megacolon—defined radiographically by non-obstructive transverse (or right) colonic dilation > 6 cm with loss of haustration on supine abdominal radiograph accompanied by systemic toxicity (fever > 38.5°C, tachycardia > 120 bpm, neutrophilic leukocytosis > 10,500/μL, hypotension, or altered mental status).

IBD Complication	Diagnostic & Radiographic Criteria	Precipitating Triggers	Definitive Medical & Surgical Management
Acute Severe Ulcerative Colitis	Truelove & Witts: >=6 bloody stools/day PLUS fever >37.8C, HR >90, Hgb <10.5 g/dL, or ESR >30 / high CRP	Medication non-adherence, NSAID use, or superimposed C. difficile / CMV colitis	Admit, NPO/bowel rest, VTE prophylaxis (LMWH—UC flares are highly prothrombotic!), stool C. diff + flexible sigmoidoscopy (biopsy for CMV), IV Methylprednisolone; rescue Infliximab or Cyclosporine at Day 3-5 if steroid-refractory
Toxic Megacolon	Transverse colon dilation >=6 cm on plain abdominal X-ray/CT + loss of haustral markings + >=3 systemic toxicity criteria (fever, tachycardia >120, leukocytosis >10.5k, anemia) + altered mental status/hypotension	Loperamide/antimotility agents, anticholinergics, opioids, hypokalemia, or barium enema/full colonoscopy during acute severe colitis	Strict NPO, NG tube decompression, knee-elbow prone rolling maneuvers, correct K+/Mg2+, broad-spectrum IV antibiotics (Ceftriaxone + Metronidazole or Zosyn), IV Hydrocortisone; emergent subtotal colectomy with end ileostomy if perforation or no improvement in 24-48h
Perianal Crohn Fistula & Abscess	Epithelialized tract connecting anal canal/rectum to perianal skin (Goodsall rule), vagina, or bladder (pneumaturia/fecaluria)	Transmural Crohn fissuring inflammation penetrating through the muscularis propria and serosa	Drain perianal abscess first + place non-cutting draining Seton (prevents premature skin closure/recurrent abscess) + Metronidazole/Cipro + Anti-TNF biologic (Infliximab)
Crohn Fibrotic Stricture vs. UC Pancolitis Surgery	Crohn small bowel obstruction vs. medically refractory UC or high-grade dysplasia	Chronic transmural collagen deposition (Crohn) vs. continuous mucosal inflammation (UC)	Total proctocolectomy with IPAA is CURATIVE for UC (and eliminates colon cancer risk, though PSC persists). Surgery is NEVER curative in Crohn disease; use bowel-sparing stricturoplasty or minimal resection to prevent Short Bowel Syndrome

Colonoscopy showing adherent yellowish-white pseudomembranes over inflamed colonic mucosa — **Clostridioides difficile Superinfection Differential in Acute IBD Flare:** Every patient presenting with an acute inflammatory bowel disease flare must undergo stool C. difficile toxin PCR/EIA testing to exclude superimposed pseudomembranous colitis prior to escalating immunosuppression. View Full Resolution

Emergency Management Protocol for Toxic Megacolon & Surgical Colectomy Triggers

Immediate management of Toxic Megacolon requires a coordinated medical-surgical ICU approach: (1) Strict bowel rest (NPO) and nasogastric tube decompression, plus frequent patient rolling (knee-elbow/prone positional changes to redistribute colonic gas); (2) Discontinue all antimotility drugs (opioids, loperamide, anticholinergics) and aggressively correct hypokalemia/hypomagnesemia; (3) Collect stool for C. difficile toxin and initiate IV broad-spectrum antibiotics (Ceftriaxone + Metronidazole or Piperacillin-Tazobactam); (4) Administer high-dose IV Corticosteroids (Methylprednisolone 60 mg/day or Hydrocortisone 100 mg IV q8h); and (5) Obtain immediate colorectal surgery consultation and serial abdominal X-rays every 12–24 hours. If the patient shows free perforation (pneumoperitoneum), massive hemorrhage, or fails to improve within 48–72 hours of IV steroids (or rescue Infliximab / Cyclosporine in severe colitis without megacolon), perform emergent subtotal colectomy with end ileostomy.

Perianal & Enteric Fistulas in Crohn Disease (Seton + Anti-TNF + Antibiotics)

Because Crohn inflammation is transmural, deep fissuring ulcers penetrate through the bowel wall serosa into adjacent hollow viscera or skin, forming fistulas in up to 35% of patients: Enterovesical fistulas present with pneumaturia (passing gas bubbles in urine), fecaluria, and recurrent polymicrobial UTIs (diagnosed via abdominal/pelvic CT with oral/rectal contrast prior to cystoscopy); enterovaginal fistulas cause passage of flatus/stool through the vagina; enteroenteric fistulas bypass absorptive bowel loops causing diarrhea/malabsorption; and complex perianal fistulas cause perirectal abscesses and purulent drainage. Management of complex perianal fistulas requires pelvic MRI or examination under anesthesia (EUA) with abscess incision/drainage and non-cutting loose Seton placement (maintains patency so an abscess does not reform while preserving anal sphincter continence!), combined with Ciprofloxacin + Metronidazole and Infliximab (Anti-TNF-α).

Why Total Proctocolectomy Is Curative in UC vs. Bowel-Sparing Stricturoplasty in Crohn

A foundational surgical distinction on board exams contrasts the operative philosophies of UC versus Crohn disease: because Ulcerative Colitis is strictly confined to the colon and rectum, a total proctocolectomy with ileal pouch-anal anastomosis (IPAA) is 100% curative of both the intestinal disease and colorectal cancer risk (note: inflammation of the ileal reservoir after IPAA is called 'pouchitis' and is treated with Ciprofloxacin or Metronidazole). Conversely, surgery is NEVER curative in Crohn disease—disease recurs at the surgical anastomosis site in > 70% of patients! Repeated extensive small bowel resections in Crohn disease lead to catastrophic Short Bowel Syndrome and TPN dependence; therefore, Crohn surgery utilizes conservative bowel-sparing stricturoplasty or limited segmental resection ONLY for refractory fibrotic obstruction, perforation, or intractable fistula/abscess.

Colorectal Cancer Surveillance in IBD & Primary Sclerosing Cholangitis (PSC) Integration

Chronic colonic mucosal inflammation in Ulcerative Colitis and Crohn colitis drives oxidative DNA damage, early TP53 loss-of-function mutations (which occur EARLY in colitis-associated dysplasia, before APC mutations—the exact inverse of the sporadic adenoma-carcinoma sequence!), and multifocal flat mucosal dysplasia that progresses rapidly to invasive Colorectal Adenocarcinoma. Key risk factors that accelerate malignant transformation include: (1) Anatomical extent of colitis (pancolitis carries the highest risk; isolated ulcerative proctitis confined to the rectum does NOT increase CRC risk above the general population!), (2) Duration of disease (> 8–10 years), (3) Severity of endoscopic/histologic inflammation (pseudopolyps, colonic strictures), and (4) Concomitant Primary Sclerosing Cholangitis (PSC), which quadruples the risk of right-sided colorectal cancer and cholangiocarcinoma.

Patient Risk Category	Surveillance Colonoscopy Initiation Timing	Ongoing Surveillance Interval & Technique	Management of Detected Dysplasia
Ulcerative Pancolitis, Left-Sided Colitis, or Crohn Colitis (≥ 1/3 of colon involved)	Begin 8 years after onset of symptoms (or diagnosis)	Every 1 to 3 years using high-definition dye-spray chromoendoscopy with targeted biopsies (or 4-quadrant random biopsies every 10 cm totaling ≥ 32 biopsies)	Endoscopically resectable polypoid lesion with clear margins: complete endoscopic resection + close surveillance
IBD (UC or Crohn) with Concomitant Primary Sclerosing Cholangitis (PSC)	Begin IMMEDIATELY at the time of PSC diagnosis (do NOT wait 8 years!)	Repeat colonoscopy ANNUALLY (every 1 year) for life; plus MRCP / ultrasound + CA 19-9 every 6–12 months for cholangiocarcinoma/gallbladder cancer	Invisible / flat high-grade dysplasia, multifocal dysplasia, or unresectable dysplasia: Total Proctocolectomy
Isolated Ulcerative Proctitis (Confined to Rectum) or Ileal-Only Crohn Disease	Standard average-risk screening starting at age 45	Every 10 years (same as general average-risk population unless family history dictates earlier)	Standard polypectomy guidelines
Colonic Stricture in Ulcerative Colitis	Immediate endoscopic evaluation with multiple biopsies	Unlike Crohn disease (where benign fibrotic strictures are common), a colonic stricture in UC is presumed malignant (adenocarcinoma) until proven otherwise!	Surgical resection / colectomy if stricture cannot be fully traversed and biopsied
Gallbladder Polyp in a Patient with PSC	Detected on routine 6–12 month RUQ ultrasound / MRCP	Over 50% of gallbladder polyps in PSC harbor invasive gallbladder adenocarcinoma	Cholecystectomy is indicated for ANY gallbladder mass/polyp (> 8 mm or any size per AASLD/EASL) in PSC

Why PSC Mandates Immediate and Annual Colonoscopic Surveillance

Patients with Primary Sclerosing Cholangitis (PSC) often harbor subclinical, mild right-sided ulcerative colitis for years before bowel symptoms become apparent, and altered secondary bile acid composition in the proximal colon acts as a potent co-carcinogen. Consequently, as soon as PSC is diagnosed, a full screening colonoscopy must be performed immediately (and if the patient had a known IBD diagnosis without prior PSC, annual colonoscopies begin the day PSC is discovered—never waiting for the 8-year mark).

Chromoendoscopy & Management of Endoscopically Invisible vs. Resectable Dysplasia

Because IBD-associated dysplasia frequently grows as flat, subtle mucosal plaques rather than pedunculated polyps, surveillance colonoscopy should be performed during clinical remission using high-definition white-light endoscopy with indigo carmine or methylene blue chromoendoscopy (or virtual narrow-band imaging) plus 4-quadrant biopsies every 10 cm. If a discrete, well-circumscribed dysplastic lesion can be completely excised en bloc by endoscopic mucosal resection (EMR) and surrounding mucosal biopsies are negative, the patient may continue intensive endoscopic surveillance. However, if biopsies reveal endoscopically invisible high-grade dysplasia, multifocal low-grade dysplasia, or an unresectable dysplastic mass, synchronous invasive carcinoma is present in up to 40–50% of colectomy specimens, mandating total proctocolectomy.

Distinguishing Infectious Colitis & Microscopic Colitis from IBD

Acute bloody diarrhea lasting < 2 weeks is most commonly infectious colitis (Campylobacter jejuni [mimics appendicitis/UC, triggers Guillain-Barré], Salmonella, Shigella, STEC E. coli O157:H7 [normal/afebrile, avoid antibiotics due to HUS risk!], or Entamoeba histolytica [flask-shaped ulcers, liver abscess]); colonic biopsy in infectious colitis shows acute neutrophilic infiltrate WITHOUT crypt architectural distortion or basal plasmacytosis. Conversely, middle-aged/elderly women taking NSAIDs, SSRIs, or PPIs who present with chronic watery non-bloody diarrhea and a completely normal-appearing colonic mucosa on colonoscopy have Microscopic Colitis (biopsy shows either a thickened subepithelial collagen band [Collagenous Colitis] or intraepithelial lymphocytes [Lymphocytic Colitis]; treated by stopping offending drugs and giving oral Budesonide).

COMLEX / OMM Integration NBOME High-Yield Correlate

Intestinal Autonomic Innervation (Cannon-Böhm Point), Chapman Reflexes & OMT in IBD

The Cannon-Böhm Autonomic Transition Point: Embryological midgut and hindgut innervation divides at the junction of the proximal two-thirds and distal one-third of the transverse colon (near the splenic flexure). Consequently, Crohn ileocolitis (affecting the terminal ileum, cecum, and ascending colon) manifests viscerosomatic facilitation at T10–T11 via the Superior Mesenteric Ganglion (SMG), with parasympathetic vagal (CN X) reflexes at the occipitoatlantal (OA) and C1–C2 junctions. Conversely, Ulcerative Colitis (involving the rectum, sigmoid, and descending colon) maps sympathetically to T12–L2 via the Inferior Mesenteric Ganglion (IMG) and parasympathetically to S2–S4 via the pelvic splanchnic nerves.
Chapman Reflexes & Counterstrain: Anterior Chapman points for the small intestine (jejunum/ileum) lie in the 9th, 10th, and 11th intercostal spaces near the costochondral junctions. Anterior Chapman points for the colon map along the anterior aspect of the iliotibial (IT) band on the lateral thigh: the right IT band corresponds to the cecum (near greater trochanter) ascending to the hepatic flexure (near the knee); the left IT band corresponds to the splenic flexure (near the left knee) descending to the sigmoid colon/rectum (at the left greater trochanter). Posterior Chapman points for the colon lie in a triangular area from the transverse processes of L2–L4 to the iliac crest.
OMT Selection & Contraindications: During acute inflammatory flares with diarrhea and cramping, high parasympathetic tone dominates; gentle mesenteric release, collateral ganglion (SMG/IMG) inhibition, and indirect myofascial release improve venous and lymphatic drainage. Absolute Contraindications: Direct deep abdominal visceral manipulation and lymphatic pumps are strictly contraindicated in toxic megacolon, acute intra-abdominal abscess, free perforation, or severe peritonitis, and lumbar/pelvic HVLA is avoided in patients with steroid-induced osteoporosis or ankylosing spondylitis (bamboo spine fracture risk).

Board Traps & Common Distractors

Trap: Performing a full diagnostic colonoscopy or barium enema during an acute severe Ulcerative Colitis flare or suspected Toxic Megacolon. Air insufflation or contrast distension of the friable, ulcerated colonic wall carries a prohibitive risk of precipitating acute colonic perforation and fatal feculent peritonitis! (If endoscopic confirmation is needed in acute severe colitis, only a cautious, unprepped flexible sigmoidoscopy with minimal air insufflation is permissible).
Trap: Administering antidiarrheal agents (loperamide, diphenoxylate-atropine), opioids, or anticholinergics to a patient having an acute IBD flare. Inhibiting colonic peristalsis paralyzes colonic smooth muscle and precipitates acute Toxic Megacolon.
Trap: Performing surgical debridement or aggressive wound excision on a painful, rapidly expanding, violaceous-bordered leg ulcer in an IBD patient (Pyoderma Gangrenosum). Pyoderma gangrenosum exhibits classic pathergy—surgical trauma dramatically worsens necrosis and ulcer expansion! Treat medically with high-dose systemic corticosteroids or Infliximab.
Trap: Starting Anti-TNF-α biologic therapy (Infliximab, Adalimumab, Certolizumab, Golimumab) without first screening for Latent Tuberculosis (QuantiFERON-TB Gold or PPD + chest X-ray) and Chronic Hepatitis B (HBsAg, anti-HBc, anti-HBs). TNF-α is essential for maintaining macrophage granuloma integrity; anti-TNF blockade causes fulminant disseminated miliary TB and fatal HBV reactivation!
Trap: Using oral 5-Aminosalicylates (Mesalamine) as primary maintenance therapy in moderate-to-severe Crohn disease or using systemic corticosteroids (Prednisone) for long-term maintenance in either Crohn or UC. Oral mesalamine has minimal efficacy in transmural Crohn disease, and corticosteroids are strictly for acute flare induction—never chronic maintenance!
Trap: Failing to test for Clostridioides difficile toxin (and CMV colitis via biopsy if steroid-refractory) in every patient presenting with an acute IBD flare. IBD patients have a vastly increased incidence of C. difficile superinfection, even without recent antibiotic exposure.
Trap: Overlooking calcium oxalate nephrolithiasis and gallstones in a patient with terminal ileal Crohn disease or prior ileocolic resection. Unabsorbed intraluminal fatty acids bind dietary calcium (saponification), leaving enteric oxalate unbound to be hyperabsorbed in the colon (enteric hyperoxaluria), while failure to reabsorb bile salts in the terminal ileum causes cholesterol supersaturation in bile.

Previous Chapter • Vol 2: Clinical Ch. 12

Cirrhosis, Portal Hypertension & Hepatic Encephalopathy

Vol 2: Clinical Ch. 14 • Next Chapter

Nephritic vs. Nephrotic Syndromes & Glomerulonephritis

Table of Contents (105 Chapters) Volume 2: Organ System Clinical Pathology • Chapter 13 of 60